Period of Royalty Obligation Sample Clauses

Period of Royalty Obligation. The royalty obligation under Section 4.1 shall commence on the date of first commercial sale of a Program Product based upon or incorporating a Licensed Validated Compound in a country and shall expire, on a country-by-country and product-by-product basis, on the later of the expiration of the last to expire patent licensed to Xxxxx under Section 2.1 above or the [ * ] anniversary of the first commercial sale of the Program Product in such country ("Royalty Term").
Sample 1Sample 2
AutoNDA by SimpleDocs
Period of Royalty Obligation. The royalty obligation under Section 3.1 shall commence on the date of first commercial sale or a Licensed Product in a country and shall expire, on a product-by-product and country-by country basis, upon the later of: (a) the last to expire patent containing a composition of matter patent claim that covers such Licensed Product [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE sECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED. (corresponding to a claim of a bushitsu tokkyo in Japan) in a country or (b) the date that is [ * ] after the date of first commercial sale of such Licensed Product in such country.
Sample 1Sample 2
Period of Royalty Obligation. Subject always to the other provisions of this Section 5.4 and to Section 5.5, for each Licensed Product, the royalty obligation shall be applicable under this Section 5.4 and 5.5 below, on a country-by-country basis in the Territory, for a period beginning on the date of First Commercial Sale of such Licensed Product in such country until the date that is the later of (a) ten (10) years from the date of such First Commercial Sale of such Licensed Product or (b) the expiration of the last to expire Valid Claim within a Sirna Patent which Covers the [***]* Licensed Product or the [***]* the Licensed Product, being sold.
Sample 1
Period of Royalty Obligation. Subject always to Section 6.3.1(c)(i) and Section 6.4, for each Product, GSK shall be required to pay royalties under Section 6.3.1, on a country-by-country basis, for a period beginning on the ** until the date that is the **.
Sample 1
Period of Royalty Obligation. The royalty obligation under Section 6.02(a) shall be payable on a quarterly basis in respect of each country in which sales of Sankyo Products occur within [ * ] after the end of each calendar quarter commencing on the date of the first commercial sale of a Sankyo Product in such country until the expiration of the last to expire patent licensed to Sankyo under Section 5.02 above or the [ * ] anniversary of the first commercial sale in such country in which there is no patent (“Royalty Term”) for such Sankyo Product. If Tularik terminates Development in the Co-Promotion Territory, then Sankyo’s milestone obligations in the Territory shall continue; provided, however, that Sankyo shall have no obligation to pay milestones on Products for which Sankyo has already paid milestones to Tularik in the Sankyo Territory. If Tularik terminates Co-Promotion or Co-Marketing activities after the Parties have begun Co-Promoting or Co-Marketing in the Territory, then Sankyo’s royalty obligations in the Territory with respect to the Product shall continue, provided, however, that Sankyo shall have no obligation to pay milestones to Tularik for the Product.
Sample 1
Period of Royalty Obligation. The royalty obligation under Section 6.03(a) shall be payable on a quarterly basis in respect of each country in the Sankyo Territory in which sales of Products occur within [ * ] after the end of each calendar quarter commencing on the date of first commercial sale of a Product in a country in the Sankyo Territory until the expiration of the last to expire patent licensed to Sankyo under Section 5.02 above or the [ * ] anniversary of the first commercial sale in such country in which there is no patent for such Product.
Sample 1

Related to Period of Royalty Obligation

  • Duration of Royalty Obligations The royalty obligations of Licensee as to each Product shall terminate on a country-by-country and product-by-product basis concurrently with the expiration of:

  • Royalty Obligations Part 2.7(e) of the Disclosure Schedule contains a complete and accurate list and summary of all royalties, fees, commissions, and other amounts payable by the Seller to any Person (other than sales commissions paid to employees according to the Seller’s standard commissions plan) upon or for the sale, or distribution of any Seller Product or the use of any Seller IP.

  • Earned Royalty In addition, Alnylam will pay Stanford earned royalties on Net Sales as follows:

  • Minimum Royalty At the beginning of each calendar year during the term of this Agreement, beginning January 1, 2016, Company shall pay to Medical School a minimum royalty of {***}. If the actual royalty payments to Medical School in any calendar year are less than the minimum royalty payment required for that year, Company shall have the right to pay Medical School the difference between the actual royalty payment and the minimum royalty payment in full satisfaction of its obligations under this Section, provided such minimum payment is made to Medical School within sixty (60) days after the conclusion of the calendar year. Waiver of any minimum royalty payment by Medical School shall not be construed as a waiver of any subsequent minimum royalty payment. If Company fails to make any minimum royalty payment within the sixty-day period, such failure shall constitute a material breach of its obligations under this Agreement, and Medical School shall have the right to terminate this Agreement in accordance with Section 8.3.

  • Royalty Period The royalty payments set forth above shall be payable for each Licensed Product on a product-by-product and country-by-country basis from the time of First Commercial Sale of Licensed Product in such country until the later of (i) [**] years from the time of First Commercial Sale of Licensed Product in such country or (ii) until the last to expire patent containing a Valid Claim providing marketing exclusivity with respect to such Licensed Product.

  • One Royalty No more than one royalty payment shall be due with respect to a sale of a particular Licensed Product. No multiple royalties shall be payable because any Licensed Product, or its manufacture, sale or use is covered by more than one Valid Claim.

  • Minimum Royalties If royalties paid to Licensor do not reach the minimum royalty amounts stated in Section 3.3 of the Patent & Technology License Agreement for the specified periods, Licensee will pay Licensor on or before the Quarterly Payment Deadline for the last Contract Quarter in the stated period an additional amount equal to the difference between the stated minimum royalty amount and the actual royalties paid to Licensor.

  • Earned Royalties Subject to of Article 7 hereof, Licensee shall pay to Licensor for the rights granted hereunder a sum equal to one and [*****] of the Net Invoice Value of Trademarked Products Sold by Licensee (the "Royalties"). The Royalties shall be remitted in accordance with Section 7.4 of this Agreement. 6.2

  • Payment of Royalties To the best of Seller’s knowledge, all royalties and in-lieu royalties with respect to the Assets which accrued or are attributable to the period prior to the Effective Time have been properly and fully paid, or are included within the suspense amounts being conveyed to Buyer pursuant to Section 11.4.

  • Payment of Royalty If the Optionor and Optionee have formed the Joint Venture under Article 4.1 hereof, then until either the Optionee or Optionor ceases to have any interest in the Joint Venture and the Property, the Optionee and Optionor shall pay their proportionate shares(based on their respective undivided interests in the Joint Venture) of any royalty payable to any governmental body.

Time is Money Join Law Insider Premium to draft better contracts faster.